Ehlerding, Emily B.
Lacognata, Saige
Jiang, Dawei
Ferreira, Carolina A.
Goel, Shreya
Hernandez, Reinier
Jeffery, Justin J.
Theuer, Charles P.
Cai, Weibo
Funding for this research was provided by:
National Institutes of Health (1R01CA169365, 1R01EB021336, P30CA014520, 5T32GM08349, T32GM008505)
National Science Foundation (DGE-1256259)
American Cancer Society (125246-RSG-13-099-01-CCE)
Article History
Received: 6 March 2017
Accepted: 25 July 2017
First Online: 18 August 2017
Compliance with ethical standards
:
: This work was supported, in part, by the University of Wisconsin – Madison, the National Institutes of Health (NIBIB/NCI 1R01CA169365, 1R01EB021336, P30CA014520, 5T32GM08349, T32GM008505), the National Science Foundation (DGE-1256259) and the American Cancer Society (125246-RSG-13-099-01-CCE).
: C.P. Theuer is the CEO of TRACON Pharmaceuticals. No potential conflicts of interest were disclosed by the other authors.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.